Kristeleit, R., Hasegawa, K., Lorusso, D., Jones, M. M., Velden, M. V. D., Zhao, J., Naumann, R. W. (2026). A phase 3, randomized, open-label study of INCB123667 versus investigator's choice of chemotherapy in patients with platinum-resistant ovarian cancer with cyclin E1 overexpression (MAESTRA 2, ENGOT-OV95, GOG-3137).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5642